Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Financial Ratios

GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Financial Ratios History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs) 47.4273.7560.9449.88
   CEPS(Rs) 56.3380.4666.9855.98
   DPS(Rs) ----
   Book NAV/Share(Rs) 483.12434.84359.30234.25
   Tax Rate(%) 25.9425.1425.3122.16
Margin Ratios
   Core EBITDA Margin(%) 25.9034.3237.6136.28
   EBIT Margin(%) 30.1336.9038.6437.98
   Pre Tax Margin(%) 29.9236.7838.5537.71
   PAT Margin (%) 22.1627.5328.7929.35
   Cash Profit Margin (%) 26.3230.0431.6432.94
Performance Ratios
   ROA(%) 9.4016.9118.8418.91
   ROE(%) 10.3418.6120.9721.29
   ROCE(%) 14.0424.8528.0027.39
   Asset Turnover(x) 0.420.610.650.64
   Sales/Fixed Asset(x) 1.612.512.491.95
   Working Capital/Sales(x) 0.570.840.751.06
Efficiency Ratios
   Fixed Capital/Sales(x) 0.620.400.400.51
   Receivable days 100.7772.4067.0883.41
   Inventory Days 162.12102.05107.06104.83
   Payable days 113.7274.3596.63108.75
Valuation Parameters
   PER(x) 26.7544.3340.66-
   PCE(x) 22.5240.6336.99-
   Price/Book(x) 2.637.526.90-
   Yield(%) ----
   EV/Net Sales(x) 4.8611.5010.84-0.50
   EV/Core EBITDA(x) 14.8529.1926.12-1.19
   EV/EBIT(x) 16.1331.1828.05-1.30
   EV/CE(x) 1.956.465.78-0.32
   M Cap / Sales 5.9312.2111.71-
Growth Ratio
   Net Sales Growth(%) -19.9127.0831.51-
   Core EBITDA Growth(%) -33.4920.6731.28-
   EBIT Growth(%) -34.6021.3433.82-
   PAT Growth(%) -35.5421.5429.00-
   EPS Growth(%) -35.7021.0122.18-
Financial Stability Ratios
   Total Debt/Equity(x) ----
   Current Ratio(x) 9.4610.0510.007.93
   Quick Ratio(x) 6.808.027.515.82
   Interest Cover(x) 142.61309.77392.33139.24
   Total Debt/Mcap(x) ----

Compare Financial Ratios of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,945.2 Cr 0.8% -3.9% 45.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,625.0 Cr 3% 2.3% 68.2% Stock Analytics
CIPLA ₹112,938.0 Cr 2.5% 0.4% 71.7% Stock Analytics
DIVIS LABORATORIES ₹101,315.0 Cr -1.6% -7% 23.8% Stock Analytics
DR REDDYS LABORATORIES ₹99,276.9 Cr -0.2% -4.9% 40.3% Stock Analytics
ZYDUS LIFESCIENCES ₹93,921.9 Cr 5% 10.4% 109.1% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.8%

-3.9%

45.7%

SENSEX

1.3%

2.6%

24%


You may also like the below Video Courses